Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about COGNITION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
Knowledge base pages for this entity
graph TD
COGNITION["COGNITION"]
COGNITION -->|"interacts"| Prefrontal_Cortex["Prefrontal Cortex"]
APOE4["APOE4"] -->|"inhibits"| COGNITION
Gut_Microbiota["Gut Microbiota"] -->|"modulates"| COGNITION
Dopaminergic_Circuits["Dopaminergic Circuits"] -->|"regulates"| COGNITION
LCPUFA_Supplementation["LCPUFA Supplementation"] -.protects against.-> COGNITION
BDNF["BDNF"] -->|"mediates"| COGNITION
Dentate_Gyrus["Dentate Gyrus"] -->|"involved_in"| COGNITION
Caffeine["Caffeine"] -->|"modulates"| COGNITION
ADENOSINE_RECEPTORS["ADENOSINE RECEPTORS"] -->|"regulates"| COGNITION| Target | Relation | Type | Str |
|---|---|---|---|
| Prefrontal Cortex | associated_with | brain_region | 0.70 |
| Prefrontal Cortex | interacts_with | brain_region | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Dopaminergic Circuits | regulates | pathway | 0.90 |
| STROKE | causes | disease | 0.90 |
| Narcolepsy Type 1 | associated_with | disease | 0.90 |
| Oveporexton | associated_with | drug | 0.90 |
| APOE4 | inhibits | protein | 0.90 |
| Alzheimer'S Disease | causes | disease | 0.90 |
| Exercise | associated_with | process | 0.90 |
| Gut Microbiota | modulates | process | 0.90 |
| Urolithin A | associated_with | compound | 0.90 |
| NLRP3 Knockout | decreases_risk | phenotype | 0.90 |
| 31915375 | are negatively associated with | paper | 0.90 |
| BDNF | regulates | gene | 0.90 |
| Gut-Brain Axis | modulates | pathway | 0.85 |
| TFEB | promotes | gene | 0.85 |
| LCPUFA | protects_against | compound | 0.85 |
| Perinatal Lcpufa Supplementation | treats | drug | 0.85 |
| Caffeine | modulates | compound | 0.85 |
| ADENOSINE RECEPTORS | regulates | receptor | 0.85 |
| BDNF | mediates | entity | 0.85 |
| PKN1-N207 | associated_with | protein | 0.85 |
| BDNF | associated_with | protein | 0.85 |
| Dentate Gyrus | involved_in | cell_type | 0.85 |
| CI-994 | upregulates | drug | 0.85 |
| COMT | regulates | gene | 0.85 |
| BDNF | regulates | gene | 0.85 |
| resistance exercise | associated_with | process | 0.85 |
| LCPUFA Supplementation | protects_against | compound | 0.85 |
| BDNF | influences | gene | 0.80 |
| exercise | associated_with | process | 0.80 |
| TET2 | modulates | protein | 0.80 |
| Neurodegenerative Diseases | causes | disease | 0.80 |
| irisin | promotes | protein | 0.80 |
| GLP-1 | improves | protein | 0.80 |
| BDNF | enhances | gene | 0.80 |
| Sleep | correlates_with | phenotype | 0.75 |
| Unfolded Protein Response | associated_with | pathway | 0.75 |
| Methylene Blue | associated_with | drug | 0.75 |
| No Donors | modulates | drug | 0.75 |
| BDNF | regulates | protein | 0.72 |
| Methylene Blue | upregulates | drug | 0.70 |
| Caspase-1 deletion | improves | process | 0.70 |
| BDNF | activates | protein | 0.70 |
| Alzheimer's disease | causes | disease | 0.70 |
| Prefrontal Cortex | inhibits | entity | 0.70 |
| Prefrontal Cortex | activates | entity | 0.70 |
| Prefrontal Cortex | interacts_with | entity | 0.70 |
| Prefrontal Cortex | associated_with | entity | 0.70 |
| prefrontal_cortex | regulates | brain_region | 0.64 |
| dopaminergic_circuits | regulates | pathway | 0.64 |
| COMT | regulates | protein | 0.60 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neurodegeneration | 2026-04-18 | 7 hypotheses Top: 0.105
neurodegeneration | 2026-04-04 | 20 hypotheses Top: 0.651
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.50 · 2026-04-18
closed · Rounds: 4 · Score: 0.86 · 2026-04-12
closed · Rounds: 5 · Score: 0.95 · 2026-04-12
Hypotheses and analyses mentioning COGNITION in their description or question text
Score: 0.642 · protein-biochemistry · 2026-04-21
**Molecular Mechanism and Rationale** The J-protein co-chaperone system represents a sophisticated cellular quality con
Score: 0.550 · neurodegeneration · 2026-04-26
Dysbiosis permits overgrowth of SIBO species and opportunistic fungi (Candida albicans, Malassezia) whose cell wall comp
Score: 0.549 · protein-folding · 2026-04-22
## Mechanistic Overview Multi-Chaperone System Co-Activation Prevents Saturation Through Complementary Substrate Recogni
Score: 0.484 · protein-biochemistry · 2026-04-26
The cellular quality control system operates through a sophisticated molecular recognition mechanism where distinct J-pr
Score: 0.455 · neurodegeneration · 2026-04-27
Specific lipid perturbations (bis(monoacylglycero)phosphate enrichment, cardiolipin externalization) create membrane mic
Score: 0.453 · neuroinflammation · 2026-04-13
## Mechanistic Overview TREM2-SYK Signaling Axis Couples OxPC Recognition to Phagocytic Clearance starts from the claim
Score: 0.450 · neuroinflammation · 2026-04-21
## Mechanistic Overview Paraneoplastic myelopathies involve CD8+ T cell recognition of viral/cancer antigens causing nec
Score: 0.380 · molecular-neurobiology · 2026-04-26
This hypothesis proposes that lncRNA-9969's selective sequestration of miR-6361 in parvalbumin interneurons operates thr
Score: 0.380 · molecular-neurobiology · 2026-04-27
This hypothesis proposes that lncRNA-9969, when upregulated by CREB1 activation in parvalbumin (PV) interneurons, employ
Score: 0.380 · protein-biochemistry · 2026-04-27
The cellular clearance of amyloidogenic oligomers operates through a two-stage molecular recognition system where expose
Score: 0.380 · neuroinflammation · 2026-04-27
The cGAS-STING pathway drives neuroinflammation in ALS through aberrant recognition of cytoplasmic mitochondrial DNA rel
Score: 0.000 · unknown disease · 2026-04-28
Target unique glycosylation patterns on tau-containing vesicles using synthetic lectins or glycan-binding proteins. Path